Paul Grossman

Telegraph Hill Partners Management Co. LLC (Telegraph Hill Partners) is a venture capital firm founded in 2001 by Robert G. Shepler, Thomas A. Raffin and Deval A. Lashkari. The firm is headquartered in San Francisco, California.

Agena Bioscience, Inc. develops, manufactures and supplies genetic analysis systems and reagents. The firm’s system are mass spectrometry-based platform for genetic analysis, and is used globally in diverse research fields such as cancer profiling for solid tumors and liquid biopsies, inherited genetic disease testing, pharmacogenetics, agricultural genomics, and clinical research. The company was founded in 2014 and is headquartered in San Diego, CA.

Argonaut Manufacturing Services, Inc. engages in providing contract manufacturing in the life science and biotech arena. It offers products launch, scale-up & volume, decline and sunset services. The company was founded in 2016 and is headquartered in Carlsbad, CA.

Verogen, Inc. develops, manufactures and sells forensic genomics products and services. It offers MiSeq FGx Forensic Genomics System, including the MiSeq FGx sequencer, ForenSeqTM DNA Signature Prep Kit, and the ForenSeq Universal Analysis Software. The company is headquartered in San Diego, CA.

Specific Diagnostics LLC engages in medical technology services. It offers treatment for blood infections. The company was founded by Paul Rhodes and Ray Martino and is headquartered in Mountain View, CA.

Nimble Therapeutics, Inc. provides drug discovery services using chemical synthesis. It enables the synthesis and screening of peptides, including scaffolded natural and modified macrocyclic peptidomimetics. The company was founded by Jigar Patel and is headquartered in Madison, WI.

Excellos, Inc. is a full-service contract development and manufacturing organization (CDMO) based in San Diego, CA. Excellos is focused on supplying cGMP cellular products and services, as well as process development and manufacturing expertise to scientists and clinicians working with cell and gene therapies. The company is dedicated to improving human life by providing critical products and services to life science research and the next generation of cell and gene therapies. Excellos accelerates cell and gene therapies by improving the quality, breadth, and variance of donor samples, and providing end-to-end cell therapy services. The company's proprietary Excellos 360 technology provides deep characterization of cells to better match patient with therapeutic development needs. The company was founded in 2020 and is led by CEO David Wellis.

Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA.